52253-69-7,
2-Amino-4-phenylthiazole hydrobromide monohydrate,
4-Phenylthiazol-2-amine hydrobromide hydrate,
2-Amino-4-Phenylthiazole Hbr H2o,
2-Thiazolamine, 4-phenyl-, monohydrobromide, monohydrate,
MFCD00150083,
2-Amino-4-phenylthiazole hydrobromide hydrate,
4-phenyl-1,3-thiazol-2-amine hydrobromide hydrate,
ACMC-1AW4H,
DSSTox_CID_4503,
AC1L23GC,
DSSTox_RID_77432,
DSSTox_GSID_24503,
SCHEMBL5325472,
CHEMBL1570415,
DTXSID0024503,
CTK8C6071,
SBVYKOGRUCDICV-UHFFFAOYSA-N,
Tox21_200171,
AKOS024318955,
CHM0020331,
LS-1321,
ACM52253697,
NCGC00091948-01,
NCGC00091948-02,
NCGC00091948-03,
NCGC00257725-01,
CAS-52253-69-7,
TC-170951,
FT-0619384,
ST50408593,
4-phenyl-1,3-thiazol-2-amine hydrate hydrobromide,
4-phenyl-1,3-thiazol-2-amine;hydrate;hydrobromide,
2-Amino-4-phenylthiazole hydrobromide monohydrate, 99%,
Phenthiazamine,
4-Phenyl-1,3-thiazol-2-amine,
CID40301,
C9-H8-N2-S.Br-H.H2-O,